共 11 条
Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
被引:79
作者:

Ahren, Bo
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Dept Med, Lund, Sweden Lund Univ, Dept Med, Lund, Sweden

Foley, James E.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ USA Lund Univ, Dept Med, Lund, Sweden

Ferrannini, Ele
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Pisa, Dept Internal Med, Pisa, Italy
Univ Pisa, CNR, Inst Clin Physiol, Pisa, Italy Lund Univ, Dept Med, Lund, Sweden

Matthews, David R.
论文数: 0 引用数: 0
h-index: 0
机构:
Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England
Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England Lund Univ, Dept Med, Lund, Sweden

Zinman, Bernard
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada Lund Univ, Dept Med, Lund, Sweden

Dejager, Sylvie
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma SAS, Clin Res, Rueil Malmaison, France Lund Univ, Dept Med, Lund, Sweden

Fonseca, Vivian A.
论文数: 0 引用数: 0
h-index: 0
机构:
Tulane Univ, Hlth Sci Ctr, Dept Endocrinol, New Orleans, LA 70118 USA Lund Univ, Dept Med, Lund, Sweden
机构:
[1] Lund Univ, Dept Med, Lund, Sweden
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Univ Pisa, Dept Internal Med, Pisa, Italy
[4] Univ Pisa, CNR, Inst Clin Physiol, Pisa, Italy
[5] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England
[6] Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England
[7] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[8] Novartis Pharma SAS, Clin Res, Rueil Malmaison, France
[9] Tulane Univ, Hlth Sci Ctr, Dept Endocrinol, New Orleans, LA 70118 USA
关键词:
BETA-CELL FUNCTION;
IV INHIBITOR VILDAGLIPTIN;
ISLET FUNCTION;
GLYCEMIA;
D O I:
10.2337/dc09-1867
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
OBJECTIVE - To determine if the dipeptidyl peptidase-4 inhibitor vildagliptin more effectively inhibits glucagon levels than the sulfonylurea glimepiride during a meal. RESEARCH DESIGN AND METHODS - Glucagon responses to a standard meal were measured at baseline and study end point (mean 1.8 years) in a trial evaluating add-on therapy to metformin with 50 mg vildagliptin bid. compared with glimepiride up to 6 mg q.d. in type 2 diabetes (baseline MC 7.3 +/- 0.6%). RESULTS - A1C and prandial glucose area under the curve (AUC)(0-2 h) were reduced similarly in both groups, whereas prandial insulin AUC(0-2 h) increased to a greater extent by glimepiride. Prandial glucagon AUC(0-2 h) (baseline 66.6 +/- 2.3 pmol . h(-1) . l(-1)) decreased by 3.4 +/- 1.6 pmol . h(-1) . l(-1) by vildagliptin (n = 137) and increased by 3.8 +/- 1.7 pmol . h(-1) . l(-1) by glimepiride (n = 121). The between-group difference was 7.3 +/- 2.1 pmol . h(-1) . l(-1) (P < 0.001). CONCLUSIONS - Vildagliptin therapy but not glimepiride improves postprandial a-cell function, which persists for at least 2 years.
引用
收藏
页码:730 / 732
页数:3
相关论文
共 11 条
[1]
The islet enhancer vildagliptin:: mechanisms of improved glucose metabolism
[J].
Ahren, B.
;
Foley, J. E.
.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE,
2008, 62
:8-14

Ahren, B.
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden

Foley, J. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmceut Corp, Dept Clin Dev & Med Affairs, E Hanover, NJ USA Lund Univ, Dept Clin Sci, SE-22184 Lund, Sweden
[2]
Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes
[J].
Ahrén, B
;
Landin-Olsson, M
;
Jansson, PA
;
Svensson, M
;
Holmes, D
;
Schweizer, A
.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2004, 89 (05)
:2078-2084

Ahrén, B
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden

Landin-Olsson, M
论文数: 0 引用数: 0
h-index: 0
机构: Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden

Jansson, PA
论文数: 0 引用数: 0
h-index: 0
机构: Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden

Svensson, M
论文数: 0 引用数: 0
h-index: 0
机构: Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden

Holmes, D
论文数: 0 引用数: 0
h-index: 0
机构: Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden

Schweizer, A
论文数: 0 引用数: 0
h-index: 0
机构: Lund Univ, Biomed Ctr B11, Dept Med, SE-21184 Lund, Sweden
[3]
Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
[J].
Ahren, Bo
;
Schweizer, Anja
;
Dejager, Sylvie
;
Dunning, Beth E.
;
Nilsson, Peter M.
;
Persson, Margaretha
;
Foley, James E.
.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2009, 94 (04)
:1236-1243

Ahren, Bo
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden

Schweizer, Anja
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, CH-4002 Basel, Switzerland Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden

Dejager, Sylvie
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, F-92506 Rueil Malmaison, France Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden

Dunning, Beth E.
论文数: 0 引用数: 0
h-index: 0
机构:
PharmaWrite LLC, Princeton, NJ 08540 USA Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden

Nilsson, Peter M.
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden

Persson, Margaretha
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden

Foley, James E.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ 07936 USA Lund Univ, Dept Clin Sci, SE-22100 Lund, Sweden
[4]
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients
[J].
Balas, Bogdan
;
Baig, Muhammad R.
;
Watson, Catherine
;
Dunning, Beth E.
;
Ligueros-Saylan, Monica
;
Wang, Yibin
;
He, Yan-Ling
;
Darland, Celia
;
Holst, Jens J.
;
Deacon, Carolyn F.
;
Cusi, Kenneth
;
Mari, Andrea
;
Foley, James E.
;
DeFronzo, Ralph A.
.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2007, 92 (04)
:1249-1255

Balas, Bogdan
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Baig, Muhammad R.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Watson, Catherine
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Dunning, Beth E.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Ligueros-Saylan, Monica
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Wang, Yibin
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

He, Yan-Ling
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Darland, Celia
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Holst, Jens J.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Deacon, Carolyn F.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Cusi, Kenneth
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Mari, Andrea
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

Foley, James E.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA

DeFronzo, Ralph A.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, Hlth Sci Ctr, Dept Med, Diabet Div, San Antonio, TX 78229 USA
[5]
Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1
[J].
de Heer, Jocelyn
;
Holst, Jens J.
.
DIABETES,
2007, 56 (02)
:438-443

de Heer, Jocelyn
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark

Holst, Jens J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark
[6]
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
[J].
Ferrannini, E.
;
Fonseca, V.
;
Zinman, B.
;
Matthews, D.
;
Ahren, B.
;
Byiers, S.
;
Shao, Q.
;
Dejager, S.
.
DIABETES OBESITY & METABOLISM,
2009, 11 (02)
:157-166

Ferrannini, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy
Univ Pisa, Dept Internal Med, Pisa, Italy Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Fonseca, V.
论文数: 0 引用数: 0
h-index: 0
机构:
Tulane Univ, Hlth Sci Ctr, Dept Endocrinol, New Orleans, LA 70118 USA Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Zinman, B.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Matthews, D.
论文数: 0 引用数: 0
h-index: 0
机构:
Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England
NIHR, Oxford Biomed Res Ctr, Oxford, England Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Ahren, B.
论文数: 0 引用数: 0
h-index: 0
机构:
Lund Univ, Dept Med, Lund, Sweden Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Byiers, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Nova Pharmaceut, Biostat, E Hanover, NJ USA Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Shao, Q.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy

Dejager, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma SAS, Clin Res, F-92506 Rueil Malmaison, France Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy
[7]
Effect of Vildagliptin on Glucagon Concentration During Meals in Patients with Type 1 Diabetes
[J].
Foley, J. E.
;
Ligueros-Saylan, M.
;
He, Y. -L
;
Holst, J. J.
;
Deacon, C. F.
;
Dunning, B. E.
;
Leone-Jones, A.
;
Yu, T.
;
Kelley, D. E.
.
HORMONE AND METABOLIC RESEARCH,
2008, 40 (10)
:727-730

Foley, J. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Corp, E Hanover, NJ USA Novartis Pharmaceut Corp, E Hanover, NJ USA

Ligueros-Saylan, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Corp, E Hanover, NJ USA Novartis Pharmaceut Corp, E Hanover, NJ USA

He, Y. -L
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Inst Biomed Res, Cambridge, MA USA Novartis Pharmaceut Corp, E Hanover, NJ USA

论文数: 引用数:
h-index:
机构:

Deacon, C. F.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Copenhagen, Denmark Novartis Pharmaceut Corp, E Hanover, NJ USA

Dunning, B. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Pharmawrite LLC, Princeton, NJ USA Novartis Pharmaceut Corp, E Hanover, NJ USA

Leone-Jones, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Pittsburgh, Pittsburgh, PA USA Novartis Pharmaceut Corp, E Hanover, NJ USA

Yu, T.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Pittsburgh, Pittsburgh, PA USA Novartis Pharmaceut Corp, E Hanover, NJ USA

Kelley, D. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Pittsburgh, Pittsburgh, PA USA Novartis Pharmaceut Corp, E Hanover, NJ USA
[8]
Characterization of the influence of vildagliptin on model-assessed β-cell function in patients with type 2 diabetes and mild hyperglycemia
[J].
Mari, Andrea
;
Scherbaum, Werner A.
;
Nilsson, Peter M.
;
Lalanne, Gerard
;
Schweizer, Anja
;
Dunning, Beth E.
;
Jauffret, Sophie
;
Foley, James E.
.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2008, 93 (01)
:103-109

Mari, Andrea
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Scherbaum, Werner A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp Duesseldorf, Dept Diabet Endocrinol & Rheumatol, D-40225 Dusseldorf, Germany Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Nilsson, Peter M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp, S-20502 Malmo, Sweden Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Lalanne, Gerard
论文数: 0 引用数: 0
h-index: 0
机构:
Med Grp, F-40000 Mt Marsan, France Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Schweizer, Anja
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, CH-4056 Basel, Switzerland Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Dunning, Beth E.
论文数: 0 引用数: 0
h-index: 0
机构:
PharmaWrite, Princeton, NJ 08540 USA Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Jauffret, Sophie
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy

Foley, James E.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA Inst Biomed Engn, Natl Res Council, I-35127 Padua, Italy
[9]
Robust improvements in fasting and prandial measures of β-cell function with vildagliptin in drug-naive patients:: analysis of pooled vildagliptin monotherapy database
[J].
Pratley, R. E.
;
Schweizer, A.
;
Rosenstock, J.
;
Foley, J. E.
;
Banerji, M. A.
;
Pi-Sunyer, F. X.
;
Mills, D.
;
Dejager, S.
.
DIABETES OBESITY & METABOLISM,
2008, 10 (10)
:931-938

Pratley, R. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Vermont, Coll Med, Burlington, VT USA Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Schweizer, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Rosenstock, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Dallas Diabet & Endocrine Ctr, Dallas, TX USA Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Foley, J. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Banerji, M. A.
论文数: 0 引用数: 0
h-index: 0
机构:
SUNY Downstate Med Ctr, New York, NY USA Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Pi-Sunyer, F. X.
论文数: 0 引用数: 0
h-index: 0
机构:
St Lukes Roosevelt Hosp, New York, NY 10025 USA Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Mills, D.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA

Dejager, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA Novartis Pharmaceut Corp, E Hanover, NJ 07936 USA
[10]
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance
[J].
Rosenstock, Julio
;
Holst, Jens J.
;
Foley, James E.
;
Deacon, Carolyn F.
;
Rendell, Marc
;
Rochotte, Erika
;
Landin-Olsson, Mona
;
Baron, Michelle A.
.
DIABETES CARE,
2008, 31 (01)
:30-35

Rosenstock, Julio
论文数: 0 引用数: 0
h-index: 0
机构:
Dallas Diabet & Endocrine Ctr, Dallas, TX USA Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Holst, Jens J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Panum Inst, Copenhagen, Denmark Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Foley, James E.
论文数: 0 引用数: 0
h-index: 0
机构:
Nova Pharmaceut Corp, E Hanover, NJ 07936 USA Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Deacon, Carolyn F.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Copenhagen, Panum Inst, Copenhagen, Denmark Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Rendell, Marc
论文数: 0 引用数: 0
h-index: 0
机构:
Creighton Diabet Ctr, Omaha, NE USA Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Rochotte, Erika
论文数: 0 引用数: 0
h-index: 0
机构:
Novarti Pharma AG, Basel, Switzerland Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Landin-Olsson, Mona
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Hosp, Lund, Sweden Nova Pharmaceut Corp, E Hanover, NJ 07936 USA

Baron, Michelle A.
论文数: 0 引用数: 0
h-index: 0
机构:
Nova Pharmaceut Corp, E Hanover, NJ 07936 USA Nova Pharmaceut Corp, E Hanover, NJ 07936 USA